Agenus | AGEN - Ebit


Agenus reported $14.4M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD 14.4M 19.26M Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celldex Therapeutics USD -87.15M 13.54M Dec/2025
CSL USD 2.64B 116M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Glaxosmithkline GBP 2.3B 1.46B Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Intrexon USD -26.3M 2.91M Jun/2024
J&J USD 6.62B 1.51B Mar/2026
Jiangsu Hengrui CNY 2.25B 848.02M Dec/2025
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
MacroGenics USD -12.1M 32.26M Dec/2025
Merck EUR 474M 738M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Northwest Biotherapeutics USD -14.32M 822K Sep/2025
Novartis USD 4.06B 530M Dec/2025
Novavax USD 20.94M 100.32M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Veracyte USD 24.63M 1.52M Dec/2025